Jacqueline Zummo's most recent trade in Protara Therapeutics Inc was a trade of 21,224 Common Stock done at an average price of $4.5 . Disclosure was reported to the exchange on March 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Sale of securities on an exchange or to another person at price $ 4.53 per share. | 26 Mar 2025 | 21,224 | 98,861 (1%) | 0% | 4.5 | 96,145 | Common Stock |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 146,000 | 146,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 24,500 | 126,639 (2%) | 0% | 0 | Common Stock | |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 21 Jan 2025 | 6,554 | 95,585 (1%) | 0% | 4.8 | 31,197 | Common Stock |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.14 per share. | 03 Jan 2025 | 2,157 | 102,139 (1%) | 0% | 6.1 | 13,244 | Common Stock |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 137,000 | 137,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Zummo Jacqueline | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 23,000 | 107,345 (1%) | 0% | 0 | Common Stock | |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 19 Jan 2024 | 3,049 | 104,296 (1%) | 0% | 1.9 | 5,824 | Common Stock |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.39 per share. | 10 Jan 2024 | 5,229 | 84,345 (1%) | 0% | 2.4 | 12,497 | Common Stock |
| Protara Therapeutics Inc | Zummo Jacqueline | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. | 03 Jan 2024 | 1,899 | 89,574 (1%) | 0% | 2.2 | 4,121 | Common Stock |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 119,300 | 119,300 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 19,900 | 91,473 (1%) | 0% | 0 | Common Stock | |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 10 Jan 2023 | 5,225 | 71,573 (1%) | 0% | 3 | 15,675 | Common Stock |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 03 Jan 2023 | 2,159 | 76,798 (1%) | 0% | 2.8 | 6,045 | Common Stock |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.27 per share. | 10 Jan 2022 | 4,603 | 78,957 (1%) | 0% | 6.3 | 28,861 | Common Stock |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 84,800 | 84,800 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 14,100 | 83,560 (1%) | 0% | 0 | Common Stock | |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Jacqueline Zummo | Chf Scientific Operations Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.16 per share. | 11 Jan 2021 | 4,653 | 69,460 (1%) | 0% | 21.2 | 98,457 | Common Stock |